Methods for the prediction of suicidality during treatment

Details for Australian Patent Application No. 2004213582 (hide)

Owner Novartis AG

Inventors Leroy, Elisabeth Marie; Polymeropoulos, Mihael Hristos; Kudaravalli, Sridhar

Agent Davies Collison Cave

Pub. Number AU-A-2004213582

PCT Pub. Number WO2004/074513

Priority 60/449,018 21.02.03 US

Filing date 20 February 2004

Wipo publication date 2 September 2004

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/074513 Priority application(s): WO2004/074513

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213583-Method and apparatus for scanning corrosion and surface defects

2004213580-Disc brake for a vehicle, in particular a commercial vehicle